Best EIS Investment Manager 2022 - Winner
Par Equity is recognised as a leader in the EIS industry for the second year in a row.
EIS Impact Award 2022 - Winner
Par Equity was recognised for its highly impactful investment and eventual realisation of Current Health, which was sold in October 2021 for $400m, making it Europe's second largest digital health exit ever.
EIS Diversity Champion 2022 - Highly Commended
Par Equity was recognised for its work on improving diversity and inclusion in tech over the last year.
Best Exit of the Year 2021 - Winner
Par Equity was selected as the winner of this award for the sale of Symphonic Software in October 2020
Best EIS Investment Manager 2021 - Winner
Par Equity is recognised as a leader in the industry, demonstrating the importance of high value engagement with both investors, advisers and portfolio businesses and the results that can be achieved.
EIS Impact Award 2021 - Highly Commended
Par Equity was recognised for its high impact work across the portfolio
Scale-Up Team of the Year 2021 - Winner
Par Equity portfolio company, Current Health, was selected as the winner, recognised as the most active and dynamic entrepreneurial team which has achieved fast growth and scale over the past year
Best Exit of the Year 2021 - Winner
Par Equity was selected as the winner of this award for the sale of Symphonic Software in October 2020
Angel Group of the Year 2021 - Winner
Par Equity was selected as the winner of this award recognising Par's activity and impact across a significant number of investments over the past year.
Best Exit of the Year 2020 – Runner Up
Par Equity was selected as runner up for its profitable exit of DeltaDNA
Best Exit of the Year 2020 – Finalist
Par Equity was selected as a finalist for its profitable exit of DeltaDNA
Best EIS Fund Manager 2020 – Highly Commended
Par Equity was recognised for high marks across exits, performance and engagement
Tax-efficient Group of the Year - Finalist
Par Equity was selected as a finalist for the awards recognising the most successful and forward-thinking providers in the areas of VCTs, EIS and BPR/IHT
Exit of the Year
Par Equity was selected as a finalist for its profitable exit of DeltaDNA
Best Generalist EIS
Par Equity was selected as a finalist for the awards recognising the most successful and forward-thinking providers in the areas of VCTs, EIS and BPR/IHT
Early Stage Deal of the Year
Par Equity was selected as a finalist for its investment in Novosound
Best EIS/SEIS Investment Exit
The win completed a hat-trick of awards recognising the firm’s turnaround of online educator ICS Learn
Exit of the Year
Par Equity's outstanding 76x return on investment made the company the deserving winner of Exit of the Year